CAH · Cardinal Health, Inc.
$234.57
-0.61% last session
End-of-day data · close of 2026-09-11
Market cap
$55B
Enterprise value
$60B
Trailing P/E
32.7
Forward P/E
16.8
Dividend yield
1.0%
Beta
0.52
Avg volume
2M
Employees
59K
Daily Change %
-0.61%
5 Days Change
-2.90%
10 Days Change
2.29%
30 Days Change
-0.11%
60 Days Change
1.78%
Month to Day Change
0.27%
Year to Day Change
17.62%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — CAH
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-19
Latest call per bank · past 12 months
RBC Capital
Outperform$276
+16.9% vs priceJP Morgan
Neutral$260
+10.2% vs priceBarclays
Overweight$275
+16.5% vs priceCitigroup
Buy$280
+18.6% vs priceMorgan Stanley
Overweight$265
+12.3% vs priceUBS
Buy$280
+18.6% vs priceWells Fargo
Overweight$277
+17.4% vs priceBank of America
Buy$260
+10.2% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-19 | RBC Capital | Initiates | Outperform | $0.00 → $276 |
| 2026-08-13 | TD Cowen | Maintains | Buy | $275 → $280 |
| 2026-08-13 | JP Morgan | Maintains | Neutral | $215 → $260 |
| 2026-08-13 | Barclays | Maintains | Overweight | $258 → $275 |
| 2026-08-12 | Citigroup | Maintains | Buy | $265 → $280 |
| 2026-08-12 | Evercore ISI Group | Maintains | Outperform | $265 → $270 |
| 2026-08-12 | Morgan Stanley | Maintains | Overweight | $255 → $265 |
| 2026-08-12 | Mizuho | Maintains | Outperform | $240 → $250 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 47 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 0.1% above the 50-day MA ($234.26).
- Price vs 200-day MA: Trading 8.7% above the 200-day MA ($215.73).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.49) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($145.95) and high ($248.61).
CAH Price Chart
Loading chart for CAH…
Fundamentals
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
More in Medical Distribution
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.